Who
Eric Duane Foster
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Ardelyx.
In numbers
- Trades disclosed
- 31
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $422K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 8 Aug 2024
- Last trade
- 21 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 May 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $10K2,598 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $13K3,389 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $9,9322,575 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $10K2,598 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $13K3,389 at $3.86 | filing |
| 21 Aug 2026filed 25 Aug 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $9,9402,575 at $3.86 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $20K3,166 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $15K2,427 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $15K2,405 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $20K3,166 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $15K2,427 at $6.27 | filing |
| 21 May 2026filed 22 May 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $15K2,405 at $6.27 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $54K9,176 at $5.87 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $7,2051,261 at $5.71 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $61 at $5.71 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $61 at $5.70 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $54K9,176 at $5.87 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $7,2001,261 at $5.71 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $61 at $5.71 | filing |
| 20 Feb 2026filed 23 Feb 2026 | ARDX ArdelyxBiotechnology | SEC FORM 4 Sold | $61 at $5.70 | filing |
News
Pomerantz LLP Issues Important Reminder to Investors in Ardelyx, Inc. ...ARDX · pr-inside.com · 25 Oct 2026Ardelyx Presents Real-World Data at ASN Kidney Week 2026 Showing Serum Phosphate Reductions Following XPHOZAH® (tenapanor) Initiation With or Without Phosphate BindersARDX · manilatimes.net · 23 Oct 2026November 16, 2026 Deadline: Join Class Action Lawsuit Against Ardelyx, ...ARDX · pr-inside.com · 20 Oct 2026
0 headlines in the last 90 days name Eric Duane Foster; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.